| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 48.622 | 45.838 | 45.151 | 37.295 | 27.563 | 31.643 | 32.341 | 34.436 | 24.903 |
| Total Income - EUR | - | 48.631 | 45.838 | 45.190 | 37.295 | 27.563 | 34.856 | 32.657 | 34.436 | 24.903 |
| Total Expenses - EUR | - | 8.764 | 9.375 | 10.311 | 8.955 | 9.332 | 9.972 | 13.803 | 20.956 | 20.130 |
| Gross Profit/Loss - EUR | - | 39.866 | 36.463 | 34.879 | 28.340 | 18.230 | 24.884 | 18.855 | 13.480 | 4.773 |
| Net Profit/Loss - EUR | - | 38.412 | 34.381 | 33.523 | 27.221 | 17.465 | 23.863 | 18.038 | 13.192 | 4.041 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Nad Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 13.990 | 10.104 | 6.337 | 2.702 | 353 | 31.998 | 28.392 | 24.717 | 20.476 |
| Current Assets | - | 35.512 | 32.507 | 33.475 | 27.787 | 45.155 | 27.658 | 60.643 | 28.349 | 1.991 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Receivables | - | 0 | 574 | 503 | 12 | 12 | 568 | 15.513 | 15.174 | 94 |
| Cash | - | 35.512 | 31.933 | 32.972 | 27.774 | 45.143 | 27.090 | 45.130 | 13.175 | 1.896 |
| Shareholders Funds | - | 38.456 | 34.434 | 33.575 | 27.272 | 44.219 | 23.911 | 18.087 | 31.223 | 4.849 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 11.046 | 8.178 | 6.237 | 3.217 | 1.289 | 35.744 | 70.949 | 21.843 | 17.617 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nad Med Srl